(arylsulfatase B -ASB). 1 Decreased enzyme activity leads to incomplete degradation of the glycosaminoglycan (GAG) dermatan sulfate, and accumulation of breakdown products in cells and tissues. These breakdown products contribute to lysosome damage, cell death, and organ dysfunction.
Although a wide spectrum of clinical severity occurs, the typical findings in a patient with significant disease include short stature, skeletal findings of dysostosis multiplex, joint dis- In the present article, Cardoso-Santos et al. 8 
